Sullivan LD - Search Results

1

Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.

Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD. Rabbani F, et al. Among authors: sullivan ld. Cancer. 1996 Aug 1;78(3):480-6. doi: 10.1002/(SICI)1097-0142(19960801)78:3<480::AID-CNCR15>3.0.CO;2-V. Cancer. 1996. PMID: 8697394

2

Should we reconsider the indications for ileo-obturator node dissection with localized prostate cancer?

Sullivan LD, Rabbani F. Sullivan LD, et al. Br J Urol. 1995 Jan;75(1):33-7. doi: 10.1111/j.1464-410x.1995.tb07228.x. Br J Urol. 1995. PMID: 7531590

3

A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.

Sato N, Gleave ME, Bruchovsky N, Rennie PS, Beraldi E, Sullivan LD. Sato N, et al. Among authors: sullivan ld. Cancer Res. 1997 Apr 15;57(8):1584-9. Cancer Res. 1997. PMID: 9108464

4

Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient?

Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD. Rabbani F, et al. Among authors: sullivan ld. Br J Urol. 1998 Feb;81(2):295-300. doi: 10.1046/j.1464-410x.1998.00497.x. Br J Urol. 1998. PMID: 9488075

5

Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up.

Gleave ME, La Bianca SE, Goldenberg SL, Jones EC, Bruchovsky N, Sullivan LD. Gleave ME, et al. Among authors: sullivan ld. Urology. 2000 Aug 1;56(2):289-94. doi: 10.1016/s0090-4295(00)00627-0. Urology. 2000. PMID: 10925096

6

Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.

Gleave ME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL, Sullivan LD. Gleave ME, et al. Among authors: sullivan ld. Urology. 1996 May;47(5):708-12. doi: 10.1016/s0090-4295(96)80016-1. Urology. 1996. PMID: 8650870

7

Low-dose cyproterone acetate plus mini-dose diethylstilbestrol--a protocol for reversible medical castration.

Goldenberg SL, Bruchovsky N, Gleave ME, Sullivan LD. Goldenberg SL, et al. Among authors: sullivan ld. Urology. 1996 Jun;47(6):882-4. doi: 10.1016/S0090-4295(96)00048-9. Urology. 1996. PMID: 8677581 Clinical Trial.

8

Optimal duration of neoadjuvant androgen withdrawal therapy before radical prostatectomy in clinically confined prostate cancer.

Gleave ME, Goldenberg SL, Jones EC, Bruchovsky N, Kinahan J, Sullivan LD. Gleave ME, et al. Among authors: sullivan ld. Semin Urol Oncol. 1996 May;14(2 Suppl 2):39-45; discussion 46-7. Semin Urol Oncol. 1996. PMID: 8725890 Review.

9

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

Coppin CM, Gospodarowicz MK, James K, Tannock IF, Zee B, Carson J, Pater J, Sullivan LD. Coppin CM, et al. Among authors: sullivan ld. J Clin Oncol. 1996 Nov;14(11):2901-7. doi: 10.1200/JCO.1996.14.11.2901. J Clin Oncol. 1996. PMID: 8918486 Clinical Trial.

10

Neoadjuvant androgen deprivation therapy before radical prostatectomy: who is unlikely to benefit?

Rabbani F, Sullivan LD, Goldenberg SL, Stothers L. Rabbani F, et al. Among authors: sullivan ld. Br J Urol. 1997 Feb;79(2):221-5. doi: 10.1046/j.1464-410x.1997.26714.x. Br J Urol. 1997. PMID: 9052474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters